Cardiometabolic diseases in patients with inflammatory bowel disease: An evidence-based review
Krishneel Dutt, Abhinav Vasudevan, Alexander Hodge, Tuan L Nguyen, Ashish R Srinivasan
Krishneel Dutt, Abhinav Vasudevan, Alexander Hodge, Ashish R Srinivasan, Department of Gastroenterology and Hepatology, Eastern Health, Box Hill 3128, Victoria, Australia
Krishneel Dutt, Abhinav Vasudevan, Alexander Hodge, Ashish R Srinivasan, Eastern Health Clinical School, Monash University, Box Hill 3128, Victoria, Australia
Alexander Hodge, School of Biomedical Sciences, RMIT, Melbourne 3000, Victoria, Australia
Tuan L Nguyen, Department of Cardiology, Liverpool Hospital, Liverpool 2170, New South Wales, Australia
Tuan L Nguyen, Department of Cardiology, Campbelltown Hospital, Campbelltown 2560, New South Wales, Australia
Tuan L Nguyen, Department of Medicine, University of New South Wales, Sydney 2033, New South Wales, Australia
Ashish R Srinivasan, Department of Medicine, Austin Academic Centre, The University of Melbourne, Heidelberg 3083, Victoria, Australia
Author contributions: Srinivasan AR, Vasudevan A contributed to study concept and design; Dutt K, Srinivasan AR and Vasudevan A contributed to drafting of manuscript; Hodge A, Nguyen TL, Srinivasan AR, Vasudevan A contributed to critical review of manuscript.
Conflict-of-interest statement: Srinivasan AR has served as a speaker for Sandoz and Arrowtex Pharmaceuticals, and received advisory fees from Abbvie, Amgen, Arrotex Pharmaceuticals, Pfizer, Takeda Pharmaceuticals, and Dr Falk Pharmaceuticals; Hodge A has served as a speaker for Norgine and is an associate medical director consultant for Alimentiv; Vasudevan A serves on the advisory board for Abbvie, Pfizer, Ferring, and has served as a speaker for Abbvie and Pfizer. For the remaining authors, none are declared.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
https://creativecommons.org/Licenses/by-nc/4.0/ Corresponding author: Ashish R Srinivasan, PhD, Associate Professor, FRACP, Department of Gastroenterology and Hepatology, Eastern Health, 8 Arnold Street, Box Hill 3128, Victoria, Australia.
ashish.srinivasan1@gmail.com
Received: March 28, 2025
Revised: April 26, 2025
Accepted: June 9, 2025
Published online: June 28, 2025
Processing time: 91 Days and 3.3 Hours
